Expert Ratings For Agios Pharmaceuticals
Expert Ratings For Agios Pharmaceuticals
Agios Pharmaceuticals的专家评级
Agios Pharmaceuticals (NASDAQ:AGIO) has been analyzed by 4 analysts in the last three months, revealing a diverse range of perspectives from bullish to bearish.
在过去的三个月中，有4位分析师对Agios Pharmicals（纳斯达克股票代码：AGIO）进行了分析，揭示了从看涨到看跌的不同观点。
The table below provides a concise overview of recent ratings by analysts, offering insights into the changing sentiments over the past 30 days and drawing comparisons with the preceding months for a holistic perspective.
下表简要概述了分析师最近的评级，提供了对过去30天情绪变化的见解，并与前几个月进行了比较以获得整体视角。
Analysts provide deeper insights through their assessments of 12-month price targets, revealing an average target of $46.25, a high estimate of $53.00, and a low estimate of $33.00. This current average has increased by 30.91% from the previous average price target of $35.33.
分析师通过对12个月目标股价的评估提供了更深入的见解，显示平均目标价为46.25美元，最高估计为53.00美元，低估值为33.00美元。目前的平均价格较之前的平均目标价35.33美元上涨了30.91％。
Breaking Down Analyst Ratings: A...
分解分析师...
登录免费看全文
登录/注册